Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment

Last updated: May 1, 2024
Sponsor: University Ghent
Overall Status: Active - Recruiting

Phase

N/A

Condition

Deafness

Hearing Impairment

Dementia

Treatment

Audiological Assessment

Cognitive screening

Clinical Study ID

NCT06400173
ONZ-2023-0147
  • Ages 45-80
  • All Genders

Study Summary

The Montreal Cognitive Assessment (MoCA) is a screening test for detecting cognitive impairment that assesses several cognitive domains (attention and concentration, arithmetic and orientation, memory, etc.). The instructions as well as some test items of the MoCA are presented auditory (spoken). Consequently, performance on the MoCA may be co-dependent on hearing. Therefore, to rule out the possible negative influence of hearing loss on performance on the MoCA, a MoCA for individuals with hearing loss was recently developed. More specifically, the original MoCA was modified by providing the instructions audiovisually (spoken with visual support) as well as by replacing hearing-dependent items. Since replacing items may affect sensitivity and specificity, the MoCA for persons with hearing loss should be revalidated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Individuals aged 60 years or older
  • Individuals with normal vision (with lenses or glasses if needed)
  • Individuals with age-related hearing loss
  • Dutch-speaking individuals
  • Individuals capable of giving consent to participate in the study themselves
  • Individuals still residing in their own homes
  • Individuals with an official diagnosis of dementia (Alzheimer's, vascular, or mixed)or mild cognitive impairment. This inclusion criterion applies only to the group withcognitive impairment.

Exclusion

Exclusion Criteria: For individuals without cognitive impairment, the following exclusion criteria apply:

  • (History of) neurological problems (brain tumor, epilepsy, history of stroke, etc.)
  • Use of influencing medication (e.g., Ritalin and antidepressants)

Study Design

Total Participants: 450
Treatment Group(s): 2
Primary Treatment: Audiological Assessment
Phase:
Study Start date:
September 01, 2023
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • University Ghent Hospital

    Ghent, East-Flanders 9000
    Belgium

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.